Novartis’ $1.5 Billion Myricx Bio Acquisition: A New Era in Cancer Treatment
Swiss pharmaceutical giant Novartis has agreed to acquire UK-based biotechnology company Myricx Bio in a deal worth up…
Swiss pharmaceutical giant Novartis has agreed to acquire UK-based biotechnology company Myricx Bio in a deal worth up…